Scientific Research on Blood Alcohol Content

A curated collection of peer-reviewed scientific papers on blood alcohol content, alcohol metabolism, impairment, and related topics. Each entry includes a link to the full publication.

Browse by Topic

Pharmacokinetics & Metabolism

Die theoretischen Grundlagen und die praktische Verwendbarkeit der gerichtlich-medizinischen Alkoholbestimmung (The Theoretical Foundations and Practical Applicability of Forensic Alcohol Determination)

Widmark, E. M. P.

Urban & Schwarzenberg, Berlin (1932)

Overview

This foundational monograph introduced the pharmacokinetic model for estimating blood alcohol concentration (BAC) based on the amount of alcohol consumed, body weight, and a gender-specific distribution ratio (now known as the Widmark factor). Widmark demonstrated that alcohol distributes through total body water and is eliminated from the bloodstream at a nearly constant rate (zero-order kinetics), approximately 0.015 g/dL per hour. The Widmark formula — BAC = (A / (r × W)) − (β × t) — where A is the mass of alcohol consumed, r is the Widmark factor (0.68 for men, 0.55 for women), W is body weight, β is the elimination rate, and t is time — became the standard model used worldwide in forensic toxicology and clinical practice for retrospective and prospective BAC estimation.

Read Full Paper
Cite this paper (APA)
Widmark, E. M. P. (1932). Die theoretischen Grundlagen und die praktische Verwendbarkeit der gerichtlich-medizinischen Alkoholbestimmung (The Theoretical Foundations and Practical Applicability of Forensic Alcohol Determination). *Urban & Schwarzenberg, Berlin*.

Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework

Jones, A. W.

Forensic Science International, 200(1–3), pp. 1–20 (2010)

DOI: 10.1016/j.forsciint.2010.02.021

PMID: 20304569

Overview

This comprehensive review synthesized data from numerous controlled drinking studies to establish evidence-based elimination rates of ethanol from blood. The analysis covered studies involving thousands of subjects and confirmed that the mean elimination rate of ethanol is approximately 0.015 g/100 mL/h (range 0.010–0.025 g/100 mL/h), following predominantly zero-order kinetics at moderate-to-high BAC levels. The review discussed inter-individual variability attributable to genetic polymorphisms in alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), chronic alcohol use, liver function, and fed versus fasted states. The findings have direct applications in forensic casework for retrograde extrapolation of BAC to the time of an alleged offense.

Read Full Paper
Cite this paper (APA)
Jones, A. W. (2010). Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework. *Forensic Science International*, 200(1–3), 1–20. https://doi.org/10.1016/j.forsciint.2010.02.021

Alcohol metabolism

Cederbaum, A. I.

Clinics in Liver Disease, 16(4), pp. 667–685 (2012)

DOI: 10.1016/j.cld.2012.08.002

PMID: 23101976

Overview

This review article provides a detailed examination of the biochemical pathways involved in alcohol metabolism in humans. The primary pathway involves alcohol dehydrogenase (ADH) in the liver cytosol, which oxidizes ethanol to acetaldehyde, followed by further oxidation to acetate by aldehyde dehydrogenase (ALDH) in the mitochondria. The microsomal ethanol-oxidizing system (MEOS), involving cytochrome P450 2E1 (CYP2E1), serves as a secondary pathway that becomes increasingly significant at higher blood alcohol levels and with chronic alcohol consumption. The article also discusses the role of catalase, the generation of reactive oxygen species (ROS) during alcohol oxidation, and how genetic polymorphisms in ADH and ALDH isoforms influence alcohol metabolism rates and susceptibility to alcohol-related organ damage.

Read Full Paper
Cite this paper (APA)
Cederbaum, A. I. (2012). Alcohol metabolism. *Clinics in Liver Disease*, 16(4), 667–685. https://doi.org/10.1016/j.cld.2012.08.002

Sex Differences

High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism

Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S.

New England Journal of Medicine, 322(2), pp. 95–99 (1990)

DOI: 10.1056/NEJM199001113220205

PMID: 2248624

Overview

This landmark study investigated why women achieve higher blood alcohol concentrations than men after consuming equivalent amounts of alcohol relative to body weight. The researchers measured gastric alcohol dehydrogenase (ADH) activity and first-pass metabolism of ethanol in men and women, including both non-alcoholic and alcoholic subjects. Results showed that women had significantly lower gastric ADH activity than men, leading to reduced first-pass metabolism and greater bioavailability of ingested ethanol. In alcoholic women, gastric ADH activity was virtually absent, resulting in blood alcohol levels approaching those expected from intravenous administration. These findings provided a biochemical explanation for the well-known sex difference in alcohol vulnerability and have direct implications for BAC estimation models that use gender-specific distribution factors.

Read Full Paper
Cite this paper (APA)
Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990). High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. *New England Journal of Medicine*, 322(2), 95–99. https://doi.org/10.1056/NEJM199001113220205

Impairment & Driving

Alcohol-induced impairment of central nervous system function: behavioral skills involved in driving

Mitchell, M. C.

Journal of Studies on Alcohol, Supplement, 10, pp. 109–116 (1985)

DOI: 10.15288/jsas.1985.s10.109

Overview

This review examined the neuropharmacological mechanisms through which alcohol impairs the central nervous system functions critical for safe driving. The study detailed how ethanol acts as a central nervous system depressant by enhancing gamma-aminobutyric acid (GABA) receptor activity and inhibiting glutamate (NMDA) receptor function, leading to progressive impairment of cognitive and psychomotor skills. At BAC levels of 0.05–0.08%, measurable deficits were observed in divided attention, reaction time, eye-hand coordination, and visual tracking. The review highlighted that tolerance may mitigate some subjective effects but does not eliminate objective performance impairment, a critical distinction for understanding impaired driving risk in chronic drinkers.

Read Full Paper
Cite this paper (APA)
Mitchell, M. C. (1985). Alcohol-induced impairment of central nervous system function: behavioral skills involved in driving. *Journal of Studies on Alcohol, Supplement*, 10, 109–116. https://doi.org/10.15288/jsas.1985.s10.109

Health Effects

Alcohol and the liver: 1994 update

Lieber, C. S.

Gastroenterology, 106(4), pp. 1085–1105 (1994)

DOI: 10.1016/0016-5085(94)90772-2

PMID: 8143977

Overview

This seminal review comprehensively examined the relationship between alcohol consumption and liver pathology. Lieber detailed the progression from fatty liver (steatosis) through alcoholic hepatitis to cirrhosis, emphasizing the central role of the microsomal ethanol-oxidizing system (MEOS) and CYP2E1 induction in chronic drinkers. The review described how chronic alcohol consumption upregulates CYP2E1 activity, increasing the rate of ethanol metabolism but also generating greater quantities of reactive oxygen species and toxic metabolites, including acetaldehyde. The paper discussed thresholds of alcohol intake associated with liver disease (generally above 40–80 g/day over extended periods) and how nutritional status, genetic factors, and hepatitis virus co-infection modulate susceptibility. These mechanisms are directly relevant to understanding why chronic drinkers may exhibit altered BAC elimination rates.

Read Full Paper
Cite this paper (APA)
Lieber, C. S. (1994). Alcohol and the liver: 1994 update. *Gastroenterology*, 106(4), 1085–1105. https://doi.org/10.1016/0016-5085(94)90772-2

Public Health

National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study

Shield, K. D., Manthey, J., Rylett, M., Probst, C., Wettlaufer, A., Parry, C. D. H., & Rehm, J.

The Lancet Public Health, 5(1), pp. e51–e61 (2020)

DOI: 10.1016/S2468-2667(19)30231-2

PMID: 31910980

Overview

This large-scale comparative risk assessment analyzed the global burden of disease attributable to alcohol consumption using data from the Global Burden of Disease Study. The study estimated that in 2016, alcohol use accounted for approximately 2.84 million deaths (5.3% of all deaths) and 99.2 million disability-adjusted life years (DALYs) worldwide. The leading causes of alcohol-attributable death were cardiovascular diseases, cancers (particularly of the digestive system), and injuries (including road traffic accidents). The study found that the burden was highest among males aged 15–49 years, for whom alcohol was the leading risk factor for premature death. The analysis underscored the importance of public health interventions including BAC-based drinking guidelines and limits for driving.

Read Full Paper
Cite this paper (APA)
Shield, K. D., Manthey, J., Rylett, M., Probst, C., Wettlaufer, A., Parry, C. D. H., & Rehm, J. (2020). National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. *The Lancet Public Health*, 5(1), e51–e61. https://doi.org/10.1016/S2468-2667(19)30231-2

About This Collection

The overviews presented on this page are summaries of peer-reviewed scientific research. We have compiled these references to help users understand the science behind blood alcohol content estimation. All papers are linked to their original sources — we encourage you to read the full publications for complete details.

This collection is for educational purposes only and does not constitute medical or legal advice. If you have concerns about alcohol use, please consult a healthcare professional.